Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Recent anticancer cytotoxic agents.

Cozzi P, Mongelli N, Suarato A.

Curr Med Chem Anticancer Agents. 2004 Mar;4(2):93-121. Review.

PMID:
15032717
2.

Camptothecin poly[n-(2-hydroxypropyl) methacrylamide] copolymers in antitopoisomerase-I tumor therapy: intratumor release and antitumor efficacy.

Zamai M, VandeVen M, Farao M, Gratton E, Ghiglieri A, Castelli MG, Fontana E, D'Argy R, Fiorino A, Pesenti E, Suarato A, Caiolfa VR.

Mol Cancer Ther. 2003 Jan;2(1):29-40.

3.

Polymer-bound camptothecin: initial biodistribution and antitumour activity studies.

Caiolfa VR, Zamai M, Fiorino A, Frigerio E, Pellizzoni C, d'Argy R, Ghiglieri A, Castelli MG, Farao M, Pesenti E, Gigli M, Angelucci F, Suarato A.

J Control Release. 2000 Mar 1;65(1-2):105-19.

PMID:
10699275
4.

Mechanism, structure-activity studies, and potential applications of glutathione S-transferase-catalyzed cleavage of sulfonamides.

Zhao Z, Koeplinger KA, Peterson T, Conradi RA, Burton PS, Suarato A, Heinrikson RL, Tomasselli AG.

Drug Metab Dispos. 1999 Sep;27(9):992-8.

PMID:
10460797
5.

Ring-B modified anthracyclines.

Suarato A, Angelucci F, Geroni C.

Curr Pharm Des. 1999 Mar;5(3):217-27. Review.

PMID:
10066891
6.
7.

Effectiveness of anthracycline against experimental prion disease in Syrian hamsters.

Tagliavini F, McArthur RA, Canciani B, Giaccone G, Porro M, Bugiani M, Lievens PM, Bugiani O, Peri E, Dall'Ara P, Rocchi M, Poli G, Forloni G, Bandiera T, Varasi M, Suarato A, Cassutti P, Cervini MA, Lansen J, Salmona M, Post C.

Science. 1997 May 16;276(5315):1119-22.

8.

Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives.

Ripamonti M, Capolongo L, Melegaro G, Gornati C, Bargiotti A, Caruso M, Grandi M, Suarato A.

Invest New Drugs. 1996;14(2):139-46.

PMID:
8913834
9.

Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.

Capranico G, Supino R, Binaschi M, Capolongo L, Grandi M, Suarato A, Zunino F.

Mol Pharmacol. 1994 May;45(5):908-15.

PMID:
8190107
10.

Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR.

Mariani M, Capolongo L, Suarato A, Bargiotti A, Mongelli N, Grandi M, Beck WT.

Invest New Drugs. 1994;12(2):93-7.

PMID:
7860237
11.

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.

Ripamonti M, Pezzoni G, Pesenti E, Pastori A, Farao M, Bargiotti A, Suarato A, Spreafico F, Grandi M.

Br J Cancer. 1992 May;65(5):703-7.

12.

[New anthracyclines and multidrug resistance].

Grandi M, Ballinari D, Capolongo L, Pastori A, Ripamonti M, Suarato A, Spreafico F.

Haematologica. 1991 Jun;76 Suppl 3:181-3. Review. Italian. No abstract available.

PMID:
1752512
13.

[Anthracycline++ resistance and possibilities of overcoming it].

Ballinari D, Suarato A, Grandi M, Spreafico F.

G Ital Chemioter. 1991 Jan-Dec;38(1-3):99-101. Italian. No abstract available.

PMID:
1365623
14.

Novel anthracycline analogs.

Grandi M, Pezzoni G, Ballinari D, Capolongo L, Suarato A, Bargiotti A, Faiardi D, Spreafico F.

Cancer Treat Rev. 1990 Sep;17(2-3):133-8. Review. No abstract available.

PMID:
2272029
15.

Doxorubicin-3'-NH-oestrone-17-oxime-ethyl-carbonyl, a doxorubicin-oestrone conjugate that does not redox cycle in rat liver microsomes.

Hartman NG, Patterson LH, Workman P, Suarato A, Angelucci F.

Biochem Pharmacol. 1990 Sep 1;40(5):1164-7.

PMID:
2167681
16.
17.

Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin.

Barbieri B, Giuliani FC, Bordoni T, Casazza AM, Geroni C, Bellini O, Suarato A, Gioia B, Penco S, Arcamone F.

Cancer Res. 1987 Aug 1;47(15):4001-6.

18.

4-Demethoxy-4-hydroxydaunorubicin 6-methyl ether and 11-methyl ether, two active isomers of daunorubicin.

Masi P, Suarato A, Giardino P, Iraci G, Bernardi L, Arcamone F.

Farmaco Sci. 1980 May;35(5):347-56.

PMID:
7450036
19.

Doxorubicin 14-ethers.

Masi P, Suarato A, Giardino P, Bernardi L, Arcamone F.

Farmaco Sci. 1979 Oct;34(10):907-13.

PMID:
510533
20.

4-Demethoxy-4-alkoxydaunorubicins.

Bernardi L, Masi P, Sapini O, Suarato A, Arcamone F.

Farmaco Sci. 1979 Oct;34(10):884-9.

PMID:
510530
21.

Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.

Cassinelli G, Grein A, Masi P, Suarato A, Bernardi L, Arcamone F, Di Marco A, Casazza AM, Pratesi G, Soranzo C.

J Antibiot (Tokyo). 1978 Mar;31(3):178-84.

22.

beta-lactam antibiotics. Novel synthetic routes to cephem-ring system from beta-lactam thiazolines via hydrazinothioazetidinones.

Franceschi G, Foglio M, Masi P, Suarato A, Palamidessi G, Bernardi L, Arcamone-Cainelli G.

J Am Chem Soc. 1977 Jan 5;99(1):248-50. No abstract available.

PMID:
830679
23.

The isolation and structure of trichosiderin B.

Prota G, Suarato A, Nicolaus RA.

Experientia. 1971 Dec 15;27(12):1381-3. No abstract available.

PMID:
5144831

Supplemental Content

Loading ...
Support Center